October 19, 2018
PHILADELPHIA — Rectal indomethacin dose escalation in high-risk patients undergoing endoscopic retrograde cholangiopancreatography did not confer any benefit over…
October 16, 2018
The FDA granted orphan drug designation to olaparib for the treatment of patients with pancreatic cancer, according to the agent’s manufacturer.
In the Journals Plus
August 31, 2018
The prevalence of pathogenic germline variants associated with pancreatic ductal adenocarcinoma and limitations of current methods to determine testing eligibility may…